Labyrinthitis: Definition and Management
Labyrinthitis is an acute inflammatory condition of the inner ear characterized by sudden-onset severe vertigo with concurrent profound hearing loss, distinguishing it from vestibular neuritis (vertigo without hearing loss) and requiring immediate evaluation to exclude bacterial infection and initiate appropriate treatment. 1
Clinical Presentation
Labyrinthitis presents with a distinct constellation of symptoms that differentiates it from other vestibular disorders:
- Sudden severe rotational vertigo lasting 12-36 hours with decreasing disequilibrium over the subsequent 4-5 days 1
- Profound, non-fluctuating hearing loss occurring simultaneously with vertigo onset—this concurrent hearing loss is the key distinguishing feature from vestibular neuritis 1, 2
- Tinnitus and aural fullness accompanying the hearing loss 2
- Nausea and vomiting due to severe vestibular dysfunction 1
- Typically presents as a single event rather than recurring episodes, unlike Ménière's disease 1
The symptoms are not positional or fluctuating, which helps differentiate labyrinthitis from BPPV and Ménière's disease 1.
Diagnostic Evaluation
Essential Diagnostic Steps
Obtain comprehensive audiometry immediately to document the characteristic profound sensorineural hearing loss pattern 3. The hearing loss in labyrinthitis is permanent and non-fluctuating, contrasting with the fluctuating low-to-mid frequency loss seen in Ménière's disease 1, 3.
Perform vestibular examination to identify harmonious peripheral vestibular syndrome with unidirectional horizontal nystagmus 4.
Imaging Recommendations
MRI of the brain and internal auditory canal with and without contrast is indicated when labyrinthitis is suspected to:
- Confirm the diagnosis by demonstrating intense labyrinthine enhancement on CISS (constructive interference steady state) sequences 4
- Exclude cholesteatomatous otitis media and other structural pathology 4
- Rule out central causes of acute vestibular syndrome 2
MRI plays an indispensable role in both positive and differential diagnosis of labyrinthitis 4. Temporal bone CT may show middle ear opacity if associated with otitis media but is insufficient for definitive diagnosis 4.
Distinguishing Bacterial from Viral Labyrinthitis
If there is evidence of concurrent otitis media (tympanic perforation, purulent otorrhea, middle ear opacity on imaging), obtain culture of otorrhea to identify bacterial pathogens 4. Bacterial labyrinthitis, though rare in the antibiotic era, carries higher morbidity and requires aggressive antibiotic therapy 4, 5.
Red flags suggesting bacterial labyrinthitis:
- Recent or concurrent acute otitis media or chronic otitis media with cholesteatoma 4, 5, 6
- Purulent otorrhea with tympanic perforation 4
- Associated complications: meningitis, facial paralysis, mastoiditis, or intracranial abscess 5
Management
Acute Phase Treatment
Vestibular suppressants (antihistamines, benzodiazepines) should be limited to short-term use (2-3 days maximum) during the acute severe vertigo phase only 1. The American Academy of Otolaryngology-Head and Neck Surgery emphasizes that prolonged use interferes with central vestibular compensation and delays recovery 1.
Antiemetics (metoclopramide 10 mg IV or prochlorperazine 10 mg IV) should be administered for severe nausea and vomiting, with IV route preferred when vomiting is present 2.
Antibiotic Therapy
Antibiotics should NOT be routinely prescribed for typical viral labyrinthitis, as most cases are self-limited and antibiotics are ineffective against viral pathogens 1.
However, if bacterial labyrinthitis is suspected or confirmed (based on otorrhea culture or clinical context of suppurative otitis media):
- Initiate broad-spectrum IV antibiotics immediately with coverage for common otic pathogens including Pseudomonas aeruginosa 4
- Initial empiric regimen: cefotaxime plus vancomycin, then adjust based on culture results 4
- Duration: minimum 17-25 days of IV antibiotic therapy for bacterial labyrinthitis 4
Corticosteroid Therapy
Oral corticosteroids are recommended for acute labyrinthitis to reduce inflammation and potentially improve hearing outcomes 7, 4. A typical course is 14 days of corticosteroid treatment 4.
Antiviral Therapy
Antiviral agents (acyclovir, valacyclovir) should NOT be routinely prescribed for viral labyrinthitis, as multiple randomized controlled trials have failed to demonstrate benefit, and antivirals carry potential side effects including nausea, vomiting, photosensitivity, and rarely reversible neurologic reactions 1.
Vestibular Rehabilitation
Vestibular rehabilitation therapy should be initiated after the acute phase (once severe vertigo subsides) for persistent imbalance and disequilibrium 1, 4. The American Academy of Otolaryngology-Head and Neck Surgery recommends self-administered or clinician-guided vestibular rehabilitation for chronic imbalance following the acute phase 1.
Vestibular rehabilitation is NOT recommended during acute vertigo attacks 1.
Elderly patients and those with difficulty achieving central compensation should be specifically counseled about vestibular therapy, as they are at higher risk for prolonged disability 1.
Adjunctive Therapies
Hyperbaric oxygen therapy may be considered as an adjunctive treatment, though evidence is limited 4.
Prognosis and Recovery Timeline
Most patients experience significant improvement of acute vertigo symptoms within 1-3 weeks 1.
However, the prognosis for hearing recovery is poor:
- Only 20% of patients experience subjective hearing recovery 8
- 57% of patients with suppurative labyrinthitis become completely deaf, while 43% develop mixed hearing loss 5
- 72.5% of patients still experience balance problems at median follow-up of 61 months 8
Poor prognostic factors include:
- Advanced age, which delays central vestibular compensation 1
- Presence of comorbidities affecting balance 1
- Bacterial etiology, particularly with cholesteatomatous chronic otitis media 5
When to Seek Further Evaluation
If vertigo symptoms persist beyond 3-4 weeks, further evaluation is warranted to rule out other conditions 1.
Any new or worsening neurological symptoms (focal deficits, severe headache, inability to stand or walk, downbeating nystagmus) should prompt immediate medical attention and urgent MRI to rule out central causes such as posterior circulation stroke 1, 2.
Complications and Long-Term Sequelae
Labyrinthitis ossificans is the pathological ossification of membranous labyrinthine spaces that can occur as a late complication 9, 6. This appears on MRI as decreased T2 signal intensity in the inner ear structures 6.
Bacterial labyrinthitis is frequently associated with other serious complications including:
- Labyrinthine fistula (25% of cases) 5
- Meningitis (21% of cases) 5
- Facial paralysis (21% of cases) 5
- Mastoiditis (21% of cases) 5
- Cerebellar or temporal abscess (12% combined) 5
The mortality rate, while low, is not negligible in bacterial labyrinthitis with complications 5.
Critical Pitfalls to Avoid
Do not prescribe prolonged vestibular suppressants, as they are an independent risk factor for falls (especially in elderly patients) and interfere with central compensation 1.
Do not assume viral etiology without excluding bacterial infection, particularly in patients with recent otitis media or purulent otorrhea 4, 5.
Do not rely on CT alone for diagnosis—MRI with contrast is essential for confirming labyrinthitis and excluding differential diagnoses 4.
Avoid polypharmacy in elderly patients, as combining vestibular suppressants with other medications significantly increases fall risk 1.